Cardiovascular risk age: concepts and practicalities

被引:49
作者
Cooney, Marie Therese [1 ]
Vartiainen, Erkki [2 ]
Laatikainen, Tiina [2 ]
De Bacquer, Dirk [3 ]
McGorrian, Catherine [4 ]
Dudina, Alexandra [1 ]
Graham, Ian [1 ]
机构
[1] Adelaide Meath Hosp, Dept Cardiol, Dublin 2, Ireland
[2] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland
[3] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium
[4] Mater Misericordiae Univ Hosp Dublin, Dublin, Ireland
关键词
HEART FORECAST; 10-YEAR RISK; DISEASE; FRAMINGHAM; SCORE; PREDICTION; VALIDATION; POPULATION; DERIVATION; PROFILE;
D O I
10.1136/heartjnl-2011-301478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives A young person with many risk factors may have the same level of risk as an older person with no risk factors. Thus a high-risk 40-year-old may have a risk age of 60 years or more. The aim of the study was to derive a generic equation for risk age, construct risk age charts, and explore the hypothesis that risk age is similar regardless of the cardiovascular disease (CVD) end point used. Methods The equation was generated by equating the generic formula for 10-year CVD risk (with unknown risk factor levels) to the generic formula for 10-year CVD risk in a person with age = x and ideal risk factor levels (total cholesterol 4 mmol/l, systolic blood pressure 120 mm Hg, and non-smoker) and solving for x. To examine the consistency between risk ages for different end points, a risk age based on risk of CVD fatal events and based on risk of fatal and non-fatal CVD events was derived for each of the participants in the FINRISK population study. The correlation between these risk ages was examined. Results A generic equation for risk age was derived. The generic equation could not be used for SCORE (Systematic COronary Risk Evaluation), because the age is included in the baseline. Therefore a table of SCORE risk ages was developed by looking up the risk age corresponding to each combination of risk factors in the chart. Risk age remains similar regardless of the cardiovascular end point used, which bypasses the dilemma of whether to use a risk-estimation system based on CVD mortality or on the more attractive but less reliable end point of total CVD events. On the basis of the equation, risk age is not dependent on baseline survival and therefore recalibration is not required. Conclusions Risk age is an intuitive and easily understood method for communicating about risk, particularly in younger patients, and may facilitate lifestyle change in younger patients. However, treatment decisions should be based on absolute risk, as recommended by guidelines on CVD prevention.
引用
收藏
页码:941 / 946
页数:6
相关论文
共 26 条
  • [1] [Anonymous], 2012, NZ PRIM CAR HDB
  • [2] Heart Forecast for cardiovascular risk assessment
    Asaria, Perviz
    Francis, Darrel P.
    [J]. HEART, 2011, 97 (03) : 173 - 174
  • [3] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
    Conroy, RM
    Pyörälä, K
    Fitzgerald, AP
    Sans, S
    Menotti, A
    De Backer, G
    De Bacquer, D
    Ducimetière, P
    Jousilahti, P
    Keil, U
    Njolstad, I
    Oganov, RG
    Thomsen, T
    Tunstall-Pedoe, H
    Tverdal, A
    Wedel, H
    Whincup, P
    Wilhelmsen, L
    Graham, IM
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (11) : 987 - 1003
  • [4] How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation
    Cuende, Jose I.
    Cuende, Natividad
    Calaveras-Lagartos, Javier
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (19) : 2351 - 2358
  • [5] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [6] Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
    D'Agostino, RB
    Grundy, S
    Sullivan, LM
    Wilson, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 180 - 187
  • [7] Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice
    de la Iglesia, Beatriz
    Potter, John F.
    Poulter, Neil R.
    Robins, Margaret M.
    Skinner, Jane
    [J]. HEART, 2011, 97 (06) : 491 - 499
  • [8] European guidelines on cardiovascular disease prevention in clinical practice: Full text
    Graham, Ian
    Atar, Dan
    Borch-Johnsen, Knut
    Boysen, Gudrun
    Burell, Gunilla
    Cifkova, Renata
    Dallongeville, Jean
    De Backer, Guy
    Ebrahim, Shah
    Gjelsvik, Bjorn
    Herrmann-Lingen, Christoph
    Hoes, Arno
    Humphries, Steve
    Knapton, Mike
    Perk, Joep
    Priori, Silvia G.
    Pyorala, Kalevi
    Reiner, Zeljko
    Ruilope, Luis
    Sans-Menendez, Susana
    Reimer, Wilma Scholte Op
    Weissbergh, Peter
    Wood, David
    Yarnell, John
    Zamorano, Jose Luis
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 : S1 - S113
  • [9] Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: A Randomized controlled trial
    Grover, Steven A.
    Lowensteyn, Ilka
    Joseph, Lawrence
    Kaouache, Mohammed
    Marchand, Sylvie
    Coupal, Louis
    Boudreau, Ghislain
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (21) : 2296 - 2303
  • [10] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421